Vendor, San Diego, CA
Nanocomposix, LLC
UEI C7LQTJ7DDKT9, CAGE 3ZAN8
2 awards and $110,025 obligated between January 10, 2024 and May 29, 2024, 0% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Centers for Disease Control and Prevention | $110,025 |
| Food and Drug Administration | $0 |
Industries
NAICS on the awards, by dollars.
| Research and Development in NanotechnologyNAICS 541713 | $110,025 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Competed Under SAP | 1 |
| Purchase Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30124P19063Purchase Order, May 29, 2024, Not Competed Under SAP, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Nanocomposix Lateral Flow AssayNAICS 541713, PSC 6850 | $110,025 |
| 75F40122P00454Purchase Order, January 10, 2024, Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Production of Aunp for in Vivo Analysis of BBB Safety and IntegrityNAICS 541713, PSC B529 | $0 |
- Places of performance
- CaliforniaMaryland
- Product and service codes
- 6850 Miscellaneous Chemical SpecialtiesB529 Scientific Data Studies
- Transactions
- 2 across 2 awards